Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Ractigen Therapeutics Introduces Novel Drug for ALS Treatment
Ractigen Therapeutics has unveiled RAG-17, an innovative siRNA modality designed to address Amyotrophic Lateral Sclerosis (ALS) treatment....
First-in-Disease Therapy for IgA Nephropathy by Everest Medicines
Everest Medicines has recently made an announcement regarding the approval of Nefecon, the pioneering treatment for primary immunoglobulin A nephropathy (IgAN), by the Hainan Medical Products Administration for clinical use....
HiST Pharma to Start Phase III Clinical Study to Treat Psoriasis Vulgaris
HiST Pharma, along with its wholly-owned Psoriasis Research Institute of Guangzhou (PRIG), made an announcement today regarding the approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) TC Cream....
FDA Approves Breakthrough Drug for GPP Flare Prevention
Spesolimab, a breakthrough medicine developed by Boehringer Ingelheim, shows promise in avoiding flares in individuals with generalized pustular psoriasis (GPP)....
SAB Biotherapeutics Investigational Influenza Therapeutic Launch
SAB Biotherapeutics has made an exciting announcement regarding their investigational therapeutic, SAB-176, which has received Breakthrough Therapy Designation (BTD) from the FDA....
Novel Drug Introduced by Genmab for R/R DLBCL Treatment
Genmab A/S has recently launched EPKINLY™ (epcoritamab-bysp), a groundbreaking drug designed for the treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)....
Novel Non-immunosuppressive Therapy to Treat Kidney-Related Disease
A novel non-immunosuppressive therapy FILSPARI™ (sparsentan) has been granted approval by the U.S Food and Drug Administration to treat IgA nephropathy (IgAN). Oral sparsentan is recommended to reduce proteinuria (protein in the urine) in patients at risk for disease progression because it targets the endothelin-1 and angiotensin 2 pathways, both of which promote IgAN disease progression...
Breakthrough Injection Discovered for treatment of Geographic Atrophy
SYFOVRE™ (pegcetacoplan injection), a medication that treats geographic atrophy (GA) brought on by age-related macular degeneration, has received approval from the U.S. Food and Drug Administration. (AMD). It is the first and only treatment for GA to receive FDA clearance, and it did so on the basis of promising Phase III clinical trial findings from two studies...
Novel Drug Granted Breakthrough Therapy for Hypothalamic Obesity
The U.S. Food and Drug Administration (FDA) has designated setmelanotide, a brand-new medication developed by Rhythm Pharmaceuticals, as a breakthrough therapy for the management of hypothalamic obesity. The FDA's designation of a drug as a "breakthrough therapy" is meant to expedite the development and review...
Breakthrough Designation to Vaxcyte’s VAX-24 for IPD Prevention
The 24-valent pneumococcal conjugate vaccine, “VAX-24” from Vaxcyte has been given Breakthrough Therapy status by the US Food and Drug Administration (FDA) in order to prevent invasive pneumococcal illness in adults. The decision was based on topline findings from a Phase I/II proof-of-concept research that assessed the immunogenicity...
